Surgeon‐documented postoperative plan for monitoring thyroid cancer recurrence or progression after surgery, includes clinical examinations by oncology/endocrinology/surgeon, ultrasound surveillance, calcitonin monitoring, and/or thyroglobulin monitoring. This evidence concerns the gene TG and thyroid gland carcinoma.